CGC Portfolio|Akulaku Finance ‘S Profit Increased 450% In 2021

2021 was a tremendous year of expansion and development for Akulaku Finance Indonesia with substantial gains across all financial services. Based on its financial report published on Thursday, July 14th, the company recorded a profit for 2021 of Rp 51.1 billion, compared to Rp 9.29 billion in 2020.

Article by
Article Date
Category
News

The demand for digital banking and credit services is growing globally as previously underserved regions embrace fintech opportunities.

Akulaku Finance Indonesia announced a recorded profit increase of 450% in 2021. Driven by the surge in online shopping during the pandemic, the company’s increase in profits is an indication of the acceleration of digital banking in Southeast Asia. 2021 was a tremendous year of expansion and development for Akulaku Finance Indonesia with substantial gains across all financial services. Based on its financial report published on Thursday, July 14th, the company recorded a profit for 2021 of Rp 51.1 billion, compared to Rp 9.29 billion in 2020.

“Akulaku recently celebrated its 6th anniversary, and this growth demonstrates our progress towards our aim of expanding non-traditional financial services to reach across Southeast Asia,” said company CFO Fan Zhang.

The profit growth was driven by an increase in the company’s income from consumer financing. Akulaku Finance noted that the funds obtained from consumer financing reached Rp 921.05 billion, an increase of 72%. The company’s recently launched Akulaku Buy Now Pay Later platform has grown rapidly, as people throughout Southeast Asia embrace fintech solutions for their investments, savings, and credit needs.

The successful year wasn’t just limited to digital financial services. Akulaku Finance’s total assets also increased throughout 2021. The company’s assets amounted to Rp. 1.36 trillion, a substantial jump from the previous Rp. 981.15 billion. Overall, this profit increase reflects the clear consumer demand for Akulaku’s services and reinforces Akulaku’s goal of building a fully digital financial ecosystem in Southeast Asia.

News
2022

Singleron Acquires Proteona

(3/7/2022) Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their clinical translations, today announced the acquisition of Proteona Pte. Ltd., a Singapore-based precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers across the globe. By acquiring Proteona's existing network throughout greater Asia, Europe, the US and Canada, the acquisition strengthens Singleron's position outside China and provides Singleron access to Proteona's technologies for single-cell multi-omic analysis and expertise in generating insights for the Biopharmaceutical market.

Articles
2021

华创资本卢汉杰:手术机器人和Digital Surgery的投资研究和实践

手术机器人技术壁垒高、研发资源投入大,市场规模正快速增长。为了使手术机器人提供更多的临床价值,产学投研界需要付出相当多的努力,随之而来的市场空间也非常巨大。相比于手术机器人,我们认为Digital Surgery更相对准确地反应了手术机器人现在的含义。手术机器人是一个非常生物医学工程驱动的行业,从投资人的角度看,造手术机器人的难度其实并不亚于造车,符合临床需求是其实践门槛。如果脱离临床价值,同时Workflow Efficiency设计的不好、成本控制不到位,那整个投资模型就不成立。华创资本生命科学组投资人卢汉杰撰文,分享了华创资本对于整个手术机器人或者Digital Surgery领域的一些认知,以及我们的投资逻辑和投资实践。